LindaCare Partners with Philips

LEUVEN, Belgium and STAMFORD, Conn., Aug. 29, 2019 /PRNewswire/ — Prior to the European Society of Cardiology (ESC) Congress 2019 (Paris, France, August 31September 4), LindaCare announced that it is collaborating with Philips to combine LindaCare’s innovative OnePulse™ cloud-based solution for the remote monitoring of patients with cardiac implantable electronic devices (CIEDs) with the Philips IntelliSpace Cardiovascular informatics platform. The seamless combination of LindaCare’s OnePulse™ solution with Philips IntelliSpace Cardiovascular allows clinicians to more easily access data from their patients’ CIEDs remotely. This results in a more seamless overall workflow, including alert management and triaging, supporting more proactive care. OnePulse™ will be available on Philips IntelliSpace Cardiovascular platform later this year.

“We are leading a revolution in remote patient monitoring,” said Shahram Sharif, CEO and Founder of LindaCare.  “Our OnePulse™ solution integrates transmissions from implantable cardiac devices like no other, making them easily accessible to caregivers. By combining our OnePulse™ with the IntelliSpace Cardiovascular platform, together we are creating an industry-leading standard for CIED patient follow-up and care.”

“Monitoring and follow-up of cardiac arrhythmia patients with CIEDs can be often complex, with data trapped in different silos that need to be reviewed individually,” said Calum Cunningham, Business Leader for Enterprise Diagnostic Informatics at Philips. “LindaCare’s innovative OnePulse™ solution consolidates this data, and by incorporating OnePulse™ into our IntelliSpace Cardiovascular platform, caregivers can see this additional information as part of the broader cardiovascular history of each patient, allowing them to make the most appropriate treatment decisions for each patient.”

“This step is a significant achievement in our partnership with Philips creating value for both companies, as it accelerates our market access and brings our innovation to Philips’ customers”, said Shahram Sharif.

The OnePulse™ platform aggregates data from cardiac electronic implantable devices across all manufacturers streamlining operational management of multitudes of patients.  The intuitive OnePulse™ dashboard makes transmissions from different implantable cardiac device manufacturers available on a single platform, providing efficient workflow automation and seamless integration with electronic patient records.  OnePulse™, in use in major hospitals across Europe and in the USA, aims at providing more efficient care for patients, ease of use for caregivers, and cost efficiency for health organization and administrators.

Philips IntelliSpace Cardiovascular is a web-based image and workflow management platform which streamlines the workflow of cardiology departments and across hospitals by consolidating multi-modality images and data and enabling access to an open ecosystem of cardiovascular software applications.

The ESC Congress 2019 will take place at the Paris Expo Porte de Versailles, France.
Visit LindaCare at the Digital Health Area on Level 1.

About LindaCare
LindaCare is a digital health company specializing in the development of integrated remote monitoring software solutions for chronic disease management. Created in 2015 with an initial focus on patients with heart failure and cardiac arrhythmias with cardiac implantable devices, LindaCare expanded its solutions to include providing technology enabled remote patient monitoring services, and will further extend to other chronic disease domains, integrating a wide range of remote monitored medical devices in the future. The company has operations in Europe and US. For more information, please visit www.lindacare.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/lindacare-partners-with-philips-300909179.html

SOURCE LindaCare

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

3 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago